Global Immunotherapy Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4897325
- 104 Pages
- March 2022
- Medical Devices
The United States Immunotherapy Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Immunotherapy Drugs market, reaching US$ million by the year 2028. As for the Europe Immunotherapy Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Immunotherapy Drugs players cover Roche, Merck, Novartis, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunotherapy Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immunotherapy Drugs Market Size 2017-2028
2.1.2 Immunotherapy Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Immunotherapy Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Adult Vaccines
2.2.3 Checkpoint Inhibitors
2.2.4 Interferons Alpha & Beta
2.2.5 Interleukins
2.2.6 Others
2.3 Immunotherapy Drugs Market Size by Type
2.3.1 Immunotherapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Immunotherapy Drugs Market Size Market Share by Type (2017-2022)
2.4 Immunotherapy Drugs Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune & Inflammatory Diseases
2.4.3 Infectious Diseases
2.4.4 Others
2.5 Immunotherapy Drugs Market Size by Application
2.5.1 Immunotherapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Immunotherapy Drugs Market Size Market Share by Application (2017-2022)
3 Immunotherapy Drugs Market Size by Player
3.1 Immunotherapy Drugs Market Size Market Share by Players
3.1.1 Global Immunotherapy Drugs Revenue by Players (2020-2022)
3.1.2 Global Immunotherapy Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Immunotherapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immunotherapy Drugs by Regions
4.1 Immunotherapy Drugs Market Size by Regions (2017-2022)
4.2 Americas Immunotherapy Drugs Market Size Growth (2017-2022)
4.3 APAC Immunotherapy Drugs Market Size Growth (2017-2022)
4.4 Europe Immunotherapy Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Immunotherapy Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Immunotherapy Drugs Market Size by Country (2017-2022)
5.2 Americas Immunotherapy Drugs Market Size by Type (2017-2022)
5.3 Americas Immunotherapy Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunotherapy Drugs Market Size by Region (2017-2022)
6.2 APAC Immunotherapy Drugs Market Size by Type (2017-2022)
6.3 APAC Immunotherapy Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immunotherapy Drugs by Country (2017-2022)
7.2 Europe Immunotherapy Drugs Market Size by Type (2017-2022)
7.3 Europe Immunotherapy Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immunotherapy Drugs by Region (2017-2022)
8.2 Middle East & Africa Immunotherapy Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Immunotherapy Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Immunotherapy Drugs Market Forecast
10.1 Global Immunotherapy Drugs Forecast by Regions (2023-2028)
10.1.1 Global Immunotherapy Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Immunotherapy Drugs Forecast
10.1.3 APAC Immunotherapy Drugs Forecast
10.1.4 Europe Immunotherapy Drugs Forecast
10.1.5 Middle East & Africa Immunotherapy Drugs Forecast
10.2 Americas Immunotherapy Drugs Forecast by Country (2023-2028)
10.2.1 United States Immunotherapy Drugs Market Forecast
10.2.2 Canada Immunotherapy Drugs Market Forecast
10.2.3 Mexico Immunotherapy Drugs Market Forecast
10.2.4 Brazil Immunotherapy Drugs Market Forecast
10.3 APAC Immunotherapy Drugs Forecast by Region (2023-2028)
10.3.1 China Immunotherapy Drugs Market Forecast
10.3.2 Japan Immunotherapy Drugs Market Forecast
10.3.3 Korea Immunotherapy Drugs Market Forecast
10.3.4 Southeast Asia Immunotherapy Drugs Market Forecast
10.3.5 India Immunotherapy Drugs Market Forecast
10.3.6 Australia Immunotherapy Drugs Market Forecast
10.4 Europe Immunotherapy Drugs Forecast by Country (2023-2028)
10.4.1 Germany Immunotherapy Drugs Market Forecast
10.4.2 France Immunotherapy Drugs Market Forecast
10.4.3 UK Immunotherapy Drugs Market Forecast
10.4.4 Italy Immunotherapy Drugs Market Forecast
10.4.5 Russia Immunotherapy Drugs Market Forecast
10.5 Middle East & Africa Immunotherapy Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Immunotherapy Drugs Market Forecast
10.5.2 South Africa Immunotherapy Drugs Market Forecast
10.5.3 Israel Immunotherapy Drugs Market Forecast
10.5.4 Turkey Immunotherapy Drugs Market Forecast
10.5.5 GCC Countries Immunotherapy Drugs Market Forecast
10.6 Global Immunotherapy Drugs Forecast by Type (2023-2028)
10.7 Global Immunotherapy Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Immunotherapy Drugs Product Offered
11.1.3 Roche Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Immunotherapy Drugs Product Offered
11.2.3 Merck Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Immunotherapy Drugs Product Offered
11.3.3 Novartis Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Immunotherapy Drugs Product Offered
11.4.3 Johnson & Johnson Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Information
11.5.2 Glaxosmithkline Immunotherapy Drugs Product Offered
11.5.3 Glaxosmithkline Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Glaxosmithkline Main Business Overview
11.5.5 Glaxosmithkline Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Immunotherapy Drugs Product Offered
11.6.3 Amgen Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Immunotherapy Drugs Product Offered
11.7.3 Abbvie Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Astrazeneca
11.8.1 Astrazeneca Company Information
11.8.2 Astrazeneca Immunotherapy Drugs Product Offered
11.8.3 Astrazeneca Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Astrazeneca Main Business Overview
11.8.5 Astrazeneca Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Immunotherapy Drugs Product Offered
11.9.3 Bristol-Myers Squibb Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 ELI Lilly
11.10.1 ELI Lilly Company Information
11.10.2 ELI Lilly Immunotherapy Drugs Product Offered
11.10.3 ELI Lilly Immunotherapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 ELI Lilly Main Business Overview
11.10.5 ELI Lilly Latest Developments
12 Research Findings and Conclusion
Table 1. Immunotherapy Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Adult Vaccines
Table 4. Major Players of Checkpoint Inhibitors
Table 5. Major Players of Interferons Alpha & Beta
Table 6. Major Players of Interleukins
Table 7. Major Players of Others
Table 8. Immunotherapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Immunotherapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Immunotherapy Drugs Market Size Market Share by Type (2017-2022)
Table 11. Immunotherapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Immunotherapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Immunotherapy Drugs Market Size Market Share by Application (2017-2022)
Table 14. Global Immunotherapy Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Immunotherapy Drugs Revenue Market Share by Player (2020-2022)
Table 16. Immunotherapy Drugs Key Players Head office and Products Offered
Table 17. Immunotherapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Immunotherapy Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Immunotherapy Drugs Market Size Market Share by Regions (2017-2022)
Table 22. Americas Immunotherapy Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Immunotherapy Drugs Market Size Market Share by Country (2017-2022)
Table 24. Americas Immunotherapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Immunotherapy Drugs Market Size Market Share by Type (2017-2022)
Table 26. Americas Immunotherapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Immunotherapy Drugs Market Size Market Share by Application (2017-2022)
Table 28. APAC Immunotherapy Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Immunotherapy Drugs Market Size Market Share by Region (2017-2022)
Table 30. APAC Immunotherapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Immunotherapy Drugs Market Size Market Share by Type (2017-2022)
Table 32. APAC Immunotherapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Immunotherapy Drugs Market Size Market Share by Application (2017-2022)
Table 34. Europe Immunotherapy Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Immunotherapy Drugs Market Size Market Share by Country (2017-2022)
Table 36. Europe Immunotherapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Immunotherapy Drugs Market Size Market Share by Type (2017-2022)
Table 38. Europe Immunotherapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Immunotherapy Drugs Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Immunotherapy Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Immunotherapy Drugs Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Immunotherapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Immunotherapy Drugs Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Immunotherapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Immunotherapy Drugs Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Immunotherapy Drugs
Table 47. Key Market Challenges & Risks of Immunotherapy Drugs
Table 48. Key Industry Trends of Immunotherapy Drugs
Table 49. Global Immunotherapy Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Immunotherapy Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Immunotherapy Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Immunotherapy Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Immunotherapy Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Immunotherapy Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 55. Roche Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 56. Roche Immunotherapy Drugs Product Offered
Table 57. Roche Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Roche Main Business
Table 59. Roche Latest Developments
Table 60. Merck Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 61. Merck Immunotherapy Drugs Product Offered
Table 62. Merck Main Business
Table 63. Merck Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Merck Latest Developments
Table 65. Novartis Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 66. Novartis Immunotherapy Drugs Product Offered
Table 67. Novartis Main Business
Table 68. Novartis Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Novartis Latest Developments
Table 70. Johnson & Johnson Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 71. Johnson & Johnson Immunotherapy Drugs Product Offered
Table 72. Johnson & Johnson Main Business
Table 73. Johnson & Johnson Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Johnson & Johnson Latest Developments
Table 75. Glaxosmithkline Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 76. Glaxosmithkline Immunotherapy Drugs Product Offered
Table 77. Glaxosmithkline Main Business
Table 78. Glaxosmithkline Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Glaxosmithkline Latest Developments
Table 80. Amgen Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 81. Amgen Immunotherapy Drugs Product Offered
Table 82. Amgen Main Business
Table 83. Amgen Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Amgen Latest Developments
Table 85. Abbvie Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 86. Abbvie Immunotherapy Drugs Product Offered
Table 87. Abbvie Main Business
Table 88. Abbvie Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Abbvie Latest Developments
Table 90. Astrazeneca Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 91. Astrazeneca Immunotherapy Drugs Product Offered
Table 92. Astrazeneca Main Business
Table 93. Astrazeneca Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Astrazeneca Latest Developments
Table 95. Bristol-Myers Squibb Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 96. Bristol-Myers Squibb Immunotherapy Drugs Product Offered
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Bristol-Myers Squibb Latest Developments
Table 100. ELI Lilly Details, Company Type, Immunotherapy Drugs Area Served and Its Competitors
Table 101. ELI Lilly Immunotherapy Drugs Product Offered
Table 102. ELI Lilly Main Business
Table 103. ELI Lilly Immunotherapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. ELI Lilly Latest Developments
List of Figures
Figure 1. Immunotherapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunotherapy Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Immunotherapy Drugs Market Size Market Share by Type in 2021
Figure 7. Immunotherapy Drugs in Cancer
Figure 8. Global Immunotherapy Drugs Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Immunotherapy Drugs in Autoimmune & Inflammatory Diseases
Figure 10. Global Immunotherapy Drugs Market: Autoimmune & Inflammatory Diseases (2017-2022) & ($ Millions)
Figure 11. Immunotherapy Drugs in Infectious Diseases
Figure 12. Global Immunotherapy Drugs Market: Infectious Diseases (2017-2022) & ($ Millions)
Figure 13. Immunotherapy Drugs in Others
Figure 14. Global Immunotherapy Drugs Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Immunotherapy Drugs Market Size Market Share by Application in 2021
Figure 16. Global Immunotherapy Drugs Revenue Market Share by Player in 2021
Figure 17. Global Immunotherapy Drugs Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Immunotherapy Drugs Market Size 2017-2022 ($ Millions)
Figure 19. APAC Immunotherapy Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Europe Immunotherapy Drugs Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Immunotherapy Drugs Market Size 2017-2022 ($ Millions)
Figure 22. Americas Immunotherapy Drugs Value Market Share by Country in 2021
Figure 23. Americas Immunotherapy Drugs Consumption Market Share by Type in 2021
Figure 24. Americas Immunotherapy Drugs Market Size Market Share by Application in 2021
Figure 25. United States Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Immunotherapy Drugs Market Size Market Share by Region in 2021
Figure 30. APAC Immunotherapy Drugs Market Size Market Share by Application in 2021
Figure 31. China Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Immunotherapy Drugs Market Size Market Share by Country in 2021
Figure 38. Europe Immunotherapy Drugs Market Size Market Share by Type in 2021
Figure 39. Europe Immunotherapy Drugs Market Size Market Share by Application in 2021
Figure 40. Germany Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Immunotherapy Drugs Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Immunotherapy Drugs Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Immunotherapy Drugs Market Size Market Share by Application in 2021
Figure 48. Egypt Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Immunotherapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 54. APAC Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Europe Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 57. United States Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Canada Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 61. China Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Japan Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Korea Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 65. India Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Australia Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Germany Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 68. France Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 69. UK Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Italy Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Russia Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Spain Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Israel Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Immunotherapy Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
